Multiple facets of serotonergic modulation.
Progress in Brain Research. 2021-01-01; : 3-39
DOI: 10.1016/bs.pbr.2021.02.002
Lire sur PubMed
Beyeler A(1), Ju A(2), Chagraoui A(3), Cuvelle L(4), Teixeira M(4), Di Giovanni G(5), De Deurwaerdère P(4).
Author information:
(1)Neurocentre Magendie, INSERM 1215, Université de Bordeaux, Bordeaux, France. Electronic address: .
(2)Neurocentre Magendie, INSERM 1215, Université de Bordeaux, Bordeaux, France.
(3)Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Institute for Research and Innovation in Biomedicine of Normandy (IRIB), Normandie University, UNIROUEN, INSERM U1239, Rouen, France; Department of Medical Biochemistry, Rouen University Hospital, Rouen, France.
(4)Centre National de La Recherche Scientifique, Institut des Neurosciences Intégratives et Cognitives d’Aquitaine, UMR 5287, Bordeaux, France.
(5)Laboratory of Neurophysiology, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta; Neuroscience Division, School of Biosciences, Cardiff University, Cardiff, United Kingdom. Electronic address: .
The serotonergic system of the central nervous system (CNS) has been implicated in a broad range of physiological functions and behaviors, such as cognition, mood, social interaction, sexual behavior, feeding behavior, sleep-wake cycle and thermoregulation. Serotonin (5-hydroxytryptamine, 5-HT) establishes a plethora of interactions with neurochemical systems in the CNS via its numerous 5-HT receptors and autoreceptors. The facets of this control are multiple if we consider the molecular actors playing a role in the autoregulation of 5-HT neuron activity including the 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2B, 5-HT7 receptors as well as the serotonin transporter. Moreover, extrinsic loops involving other neurotransmitters giving the other 5-HT receptors the possibility to impact 5-HT neuron activity. Grasping the complexity of these interactions is essential for the development of a variety of therapeutic strategies for cognitive defects and mood disorders. Presently we can illustrate the plurality of the mechanisms and only conceive that these 5-HT controls are likely not uniform in terms of regional and neuronal distribution. Our understanding of the specific expression patterns of these receptors on specific circuits and neuronal populations are progressing and will expand our comprehension of the function and interaction of these receptors with other chemical systems. Thus, the development of new approaches profiling the expression of 5-HT receptors and autoreceptors should reveal additional facets of the 5-HT controls of neurochemical systems in the CNS.